Epigenetic treatment of solid tumours: a review of clinical trials

Epigenetic treatment has been approved by regulatory agencies for haematological malignancies. The success observed in cutaneous lymphomas represents a proof of principle that similar results may be obtained in solid tumours. Several agents that interfere with DNA methylation-demethylation and histo...

Descripción completa

Detalles Bibliográficos
Autores principales: Nervi, Clara, De Marinis, Elisabetta, Codacci-Pisanelli, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676165/
https://www.ncbi.nlm.nih.gov/pubmed/26692909
http://dx.doi.org/10.1186/s13148-015-0157-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676165/
https://www.ncbi.nlm.nih.gov/pubmed/26692909
http://dx.doi.org/10.1186/s13148-015-0157-2

Ejemplares similares